Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma.
Cancer Biomark
; 28(3): 341-350, 2020.
Article
in En
| MEDLINE
| ID: mdl-32390596
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Carcinoma, Hepatocellular
/
Aurora Kinase A
/
Forkhead Box Protein M1
/
Sorafenib
/
Liver Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Biomark
Journal subject:
BIOQUIMICA
/
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
Netherlands